NASDAQ:RXDX
Prometheus Biosciences, Inc.
- Stock
Last Close
199.74
15/06 20:00
Market Cap
9.56B
Beta: −0.60
Volume Today
1.79M
Avg: 983.04K
PE Ratio
−63.62
PFCF: −88.63
Dec '14 | Dec '15 | Dec '16 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|---|---|
asset turnover | 0.00 - | 0.02 - | 0.02 6.94% | 0.01 43.31% | 0.01 21.33% | |||
cash per share | 3.79 - | 4.91 29.35% | 2.81 42.83% | 0.16 94.12% | 1.57 849.73% | 8.21 424.21% | 17.13 108.64% | |
company equity multiplier | 1.52 - | 1.44 5.40% | 1.53 6.01% | -1.37 189.31% | -0.61 55.23% | 1.14 286.28% | 1.10 3.77% | |
days of inventory outstanding | ||||||||
days of payables outstanding | ||||||||
days of sales outstanding | 322.53 - | 125.87 60.98% | 55.16 56.18% | |||||
dividend yield | ||||||||
ebit per revenue | -265.66 - | -14.28 - | -23.60 65.25% | -28.06 18.89% | -21.41 23.70% | |||
ebt per ebit | 1.00 - | 1.02 1.75% | 1.03 0.84% | 1.05 1.78% | 1.07 2.47% | 1.03 4.31% | 0.97 5.34% | |
effective tax rate | -0.00 - | -0.78 - | -0.19 75.20% | -0.01 92.67% | 0.03 332.67% | |||
enterprise value multiple | -12.10 - | -7.55 37.63% | -10.97 45.35% | -42.58 288.10% | -28.66 32.68% | -11.18 61.00% | -28.85 157.99% | |
fixed asset turnover | 0.02 - | 0.16 - | 2.75 1,575.49% | 2.16 21.35% | 0.22 90.05% | |||
free cash flow per share | -1.94 - | -2.02 4.13% | -2.41 18.91% | -0.76 68.45% | -0.82 7.47% | -2.06 152.97% | -3.10 50.32% | |
gross profit margin | 1 - | 1 - | 1 0% | 1 0% | 1 0% | |||
interest coverage | -34.93 - | -31.33 10.32% | -20.74 33.80% | -13.62 34.33% | -101.98 648.83% | 31.32 130.71% | ||
inventory turnover | ||||||||
long term debt to capitalization | 0.25 - | 0.15 42.04% | 0.25 69.35% | -0.08 - | 0.04 - | |||
net income per ebt | 1.00 - | 1 0.03% | 1 0% | 1.78 77.67% | 1.19 32.87% | 1.01 14.97% | 0.97 4.63% | |
net profit margin | -266.60 - | -26.59 - | -30.22 13.66% | -29.23 3.26% | -20.13 31.12% | |||
operating cash flow per share | -1.77 - | -1.89 6.72% | -2.34 23.79% | -0.75 68.04% | -0.81 8.17% | -2.03 150.33% | -3.03 49.73% | |
operating profit margin | -265.66 - | -14.28 - | -23.60 65.25% | -28.06 18.89% | -21.41 23.70% | |||
payables turnover | ||||||||
pretax profit margin | -266.52 - | -14.96 - | -25.34 69.33% | -28.83 13.77% | -20.82 27.78% | |||
price fair value | 8.28 - | 4.99 39.72% | 10.27 105.61% | -18.46 279.78% | -8.97 51.39% | 5.27 158.72% | 6.61 25.45% | |
receivables turnover | 1.13 - | 2.90 156.25% | 6.62 128.18% | |||||
return on assets | -0.47 - | -0.47 0.55% | -0.72 51.72% | -0.59 17.67% | -0.62 5.78% | -0.34 45.16% | -0.19 45.81% | |
return on capital employed | -0.51 - | -0.53 3.22% | -0.79 49.54% | -0.86 8.59% | -0.65 23.83% | -0.35 46.56% | -0.20 41.87% | |
return on equity | -0.71 - | -0.68 4.88% | -1.09 60.84% | 0.80 173.52% | 0.38 52.65% | -0.39 202.16% | -0.20 47.86% | |
total debt to capitalization | 0.27 - | 0.18 31.70% | 0.25 36.28% | -0.24 198.85% | -0.25 3.93% | 0.04 - |
All numbers in USD (except ratios and percentages)